Clinical Trial Update: Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features [Phase 4]

View source ↗

Summary

A Phase 4 interventional study evaluating Wellbutrin XL (bupropion extended-release) for major depressive disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• WELLBUTRIN XL (Bupropion hydrochloride)

Snippet

Sponsor: Chi-Un Pae | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED